Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ray

Showing results (101-110 of 229) with videos related to

Pageof 23
Sort By:
Biofouling|May 19, 2012
Sulphide production and corrosion in seawaters during exposure to FAME dieselJason S Lee, Richard I Ray, Brenda J Little, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2010
A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumorsP Schöffski, P Reichardt, J-Y Blay, et al.
Cancer|January 15, 1998
Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimensI Ray-Coquard, P Biron, T Bachelot, et al.
Foot & Ankle International|July 16, 2019
Clinical and Radiological Outcomes of Forefoot Offloading Versus Rigid Flat Shoes in Patients Undergoing Surgery of the First RayPaul M C Dearden, Robbie I Ray, Peter W Robinson, et al.
Annals of Surgery|March 1, 1980
Experimental comparison of the thrombogenicity of fibrin and PTFE flow surfacesD A Kenny, K Berger, M W Walker, et al.
Blood|July 10, 1998
A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapyJ Y Blay, A Le Cesne, C Mermet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trialsT Bachelot, I Ray-Coquard, G Catimel, et al.
Annals of Surgical Oncology|April 5, 2020
Should We Abandon Systematic Pelvic and Paraaortic Lymphadenectomy in Low-Grade Serous Ovarian Cancer?V Simon, C Ngo, E Pujade-Lauraine, et al.
The Indian Journal of Medical Research|August 1, 1973
Transplant transmission of haemagglutination-inhibiting antibodies of pox and arbovirusesJ K Sarak, S K Chakravarty, S N Ray, et al.
Bulletin Du Cancer|March 6, 2010
Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancerN Carrabin, F Mithieux, P Meeus, et al.
Pageof 23

Showing results (101-110 of 229) with videos related to

Sort By:
Pageof 23
Biofouling|May 19, 2012
Sulphide production and corrosion in seawaters during exposure to FAME dieselJason S Lee, Richard I Ray, Brenda J Little, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2010
A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumorsP Schöffski, P Reichardt, J-Y Blay, et al.
Cancer|January 15, 1998
Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimensI Ray-Coquard, P Biron, T Bachelot, et al.
Foot & Ankle International|July 16, 2019
Clinical and Radiological Outcomes of Forefoot Offloading Versus Rigid Flat Shoes in Patients Undergoing Surgery of the First RayPaul M C Dearden, Robbie I Ray, Peter W Robinson, et al.
Annals of Surgery|March 1, 1980
Experimental comparison of the thrombogenicity of fibrin and PTFE flow surfacesD A Kenny, K Berger, M W Walker, et al.
Blood|July 10, 1998
A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapyJ Y Blay, A Le Cesne, C Mermet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trialsT Bachelot, I Ray-Coquard, G Catimel, et al.
Annals of Surgical Oncology|April 5, 2020
Should We Abandon Systematic Pelvic and Paraaortic Lymphadenectomy in Low-Grade Serous Ovarian Cancer?V Simon, C Ngo, E Pujade-Lauraine, et al.
The Indian Journal of Medical Research|August 1, 1973
Transplant transmission of haemagglutination-inhibiting antibodies of pox and arbovirusesJ K Sarak, S K Chakravarty, S N Ray, et al.
Bulletin Du Cancer|March 6, 2010
Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancerN Carrabin, F Mithieux, P Meeus, et al.
Pageof 23